The ORNATE India project: Building research capacity and capability to tackle the burden of diabetic retinopathy-related blindness in India.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
Nov 2021
Historique:
entrez: 28 10 2021
pubmed: 29 10 2021
medline: 5 11 2021
Statut: ppublish

Résumé

The ORNATE India project is an interdisciplinary, multifaceted United Kingdom (UK)-India collaborative study aimed to build research capacity and capability in India and the UK to tackle the burden of diabetes-related visual impairment. For 51 months (October 2017-December 2021), this project built collaboration between six institutions in the UK and seven in India, including the Government of Kerala. Diabetic retinopathy (DR) screening models were evaluated in the public system in Kerala. An epidemiological study of diabetes and its complications was conducted through 20 centers across India covering 10 states and one union territory. The statistical analysis is not yet complete. In the UK, risk models for diabetes and its complications and artificial intelligence-aided tools are being developed. These were complemented by joint studies on various aspects of diabetes between collaborators in the UK and India. This interdisciplinary team enabled increased capability in several workstreams, resulting in an increased number of publications, development of cost-effective risk models, algorithms for risk-based screening, and policy for state-wide implementation of sustainable DR screening and treatment programs in primary care in Kerala. The increase in research capacity included multiple disciplines from field workers, administrators, project managers, project leads, screeners, graders, optometrists, nurses, general practitioners, and research associates in various disciplines. Cross-fertilization of these disciplines enabled the development of several collaborations external to this project. This collaborative project has made a significant impact on research capacity development in both India and the UK.

Identifiants

pubmed: 34708742
pii: IndianJOphthalmol_2021_69_11_3058_329255
doi: 10.4103/ijo.IJO_1505_21
pmc: PMC8725136
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3058-3063

Subventions

Organisme : Medical Research Council
ID : MR/P027881/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

None

Références

BMJ Open. 2021 Jan 19;11(1):e043590
pubmed: 33468529
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
BMJ Open. 2020 Dec 12;10(12):e039657
pubmed: 33310798
Eye (Lond). 2019 Jan;33(1):97-109
pubmed: 30401899
BMJ Open. 2017 Jan 27;7(1):e012332
pubmed: 28131997
Sci Rep. 2021 May 4;11(1):9469
pubmed: 33947946
Indian J Ophthalmol. 2016 Jan;64(1):69-75
pubmed: 26953027
Diabetes Res Clin Pract. 2006 Dec;74(3):289-94
pubmed: 16730847
Eye (Lond). 2020 Mar;34(3):420-421
pubmed: 31827270
BMJ Open. 2021 Jun 28;11(6):e040577
pubmed: 34183333
Eye (Lond). 2020 Jul;34(7):1279-1286
pubmed: 32398841
Soc Sci Med. 1992 Dec;35(11):1321-4
pubmed: 1462171
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596
pubmed: 28601585

Auteurs

Dolores Conroy (D)

Vision Sciences Department, UCL Institute of Ophthalmology, 11-43 Bath St, London, UK.

Radha Ramakrishnan (R)

Vision Sciences Department, UCL Institute of Ophthalmology, 11-43 Bath St, London, UK.

Rajiv Raman (R)

Shri Bhagwan Mahavir Vitreoretinal Services, Medical Research Foundation, Sankara Nethralaya, Chennai, India.

Ramachandran Rajalakshmi (R)

Department of Ophthalmology, Madras Diabetes Research Foundation, Chennai, India.

Padmaja Kumari Rani (PK)

Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, L V Prasad Eye Institute, Hyderabad, India.

Kim Ramasamy (K)

Department of Vitreoretinal Services, Aravind Eye Hospital, Madurai, India.

Viswananthan Mohan (V)

Department of Ophthalmology, Madras Diabetes Research Foundation, Chennai, India.

Taraprasad Das (T)

Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, L V Prasad Eye Institute, Hyderabad, India.

Rajeev Sadanandan (R)

Chief Executive Officer, Health Systems Transformation Platform, SID Campus, Qutab Institutional Area, New Delhi, India.

Gopal Netuveli (G)

Institute of Connected Communities, University of East London, Stratford Campus, London, UK.

Sobha Sivaprasad (S)

Medical Retina Department, NIHR Biomedical Research Centre, Moorfields Eye, Hospital NHS Foundation Trust, 162 City Road, London, UK and University College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH